ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keengwe, I. N
Right arrow Articles by Sharples, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keengwe, I. N
Right arrow Articles by Sharples, A.
Arch Dis Child 1999;80:553-555 ( June )

Paediatric oncology and intensive care treatments: changing trends

Isaac N Keengwea, Francesca Stansfielda, Osborn B Edenb, Nicholas D Nelhansa, Oliver R Dearlovec, Andrew Sharplesa

a Department of Intensive Care, Manchester Children's Hospital, Pendlebury, Manchester M27 4HA, UK, b Department of Oncology, Manchester Children's Hospital, c Department of Anaesthesia, Manchester Children's Hospital

Correspondence to: Dr Keengwe.

Accepted 3 February 1999

OBJECTIVES---To review the outcome of patients with childhood malignancy requiring intensive care treatment and to assess whether there is any secular trend for improved outcome.
DESIGN---Retrospective chart reviews of 74 consecutive admissions to a paediatric intensive care unit from a regional paediatric oncology centre between 1990 and 1997. During the same period there were 6419 admissions to the oncology unit, 814 of whom were new cases.
RESULTS---The overall survival at discharge from the intensive care unit was 49 of 74. Patients with either systemic or respiratory infection requiring ventilation had the poorest survival (13 of 31) whereas postoperative patients had the best survival (15 of 15). However, patients with respiratory or systemic infection who required inotropic support with more than three agents all died compared with about one quarter of those needing no inotrope. All patients with systemic or respiratory infective illness were neutropenic and positive microbiological identification was possible in 13 of 21 and five of 18, respectively. Non-survivors had a higher mean acute physiology and chronic health evaluation system (APACHE-II) score than survivors (24.2 v 15.94, respectively) but no patient with a score of > 27 survived.
CONCLUSION---Compared with previous series, there has been a great improvement in survival of oncology patients admitted to the intensive care unit especially those with either systemic or respiratory infection needing ventilation. Full intensive care treatment should be provided for these patients.


Keywords: intensive care; oncology; haematology; infection; ventilation; inotropes; survival


© 1999 by Archives of Disease in Childhood



This article has been cited by other articles:


Home page
JCOHome page
G. Gatta, R. Capocaccia, C. Stiller, P. Kaatsch, F. Berrino, M. Terenziani, and the EUROCARE Working Group
Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
J. Clin. Oncol., June 1, 2005; 23(16): 3742 - 3751.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A. WADE
Derivation versus validation
Arch. Dis. Child., December 1, 2000; 83(6): 459 - 460.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health